Skip to main content
Article thumbnail
Location of Repository

Carboxypeptidase 4 gene variants and early-onset intermediate-to-high risk prostate cancer

By Phillip L Ross, Iona Cheng, Xin Liu, Mine S Cicek, Peter R Carroll, Graham Casey and John S Witte
Topics: Research Article
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:2657151
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (1999). Carboxypeptidase A3 (CPA3): a novel gene highly induced by histone deacetylase inhibitors during differentiation of prostate epithelial cancer cells. Cancer Res
    2. (2006). Case-control studies in the genomic era: a clinician's guide. Lancet Neurol
    3. (2000). Catalona WJ: Genomewide scan for prostate cancer-aggressiveness loci.
    4. (1993). PC: The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer [see comments].
    5. (1997). Pearson JD: Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update [see comments] [published erratum appears in JAMA
    6. (1999). Pretreatment Nomogram for Prostate-Specific Antigen Recurrence After Radical Prostatectomy or External-Beam Radiation Therapy for Clinically Localized Prostate Cancer.
    7. (1998). PT: A Preoperative Nomogram for Disease Recurrence Following Radical Prostatectomy for Prostate Cancer.
    8. The Veterans Administration Cooperative Research Group: Histologic Grading and Clinical Staging of Prostate Cancer.
    9. (2007). Thun MJ: Cancer statistics,

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.